GlassScriptPhysician profile
Robyn R Leitner
NPI 1659342277
$3,453.06
in general payments reported to CMS, 2019-2025
40 companies · $1,051 in 2025
The $1,051 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $435 · 2020: $141 · 2021: $428 · 2022: $484 · 2023: $475 · 2024: $438 · 2025: $1,051.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,964.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,964.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $287.59 | 2019-2025 | |
| Axonics, INC. | $248.70 | 2021-2023 | Axonics, Bulkamid |
| Calyxo, INC. | $227.71 | 2025 | Cvac Aspiration System |
| Boston Scientific Corporation | $226.32 | 2021-2025 | Axonics, Lithovue |
| Edap Technomed INC | $198.07 | 2025 | |
| Janssen Biotech, INC. | $183.69 | 2019-2025 | Erleada |
| Tolmar, INC. | $148.98 | 2023-2025 | Eligard |
| Medtronic, INC. | $132.57 | 2021-2022 | |
| Coloplast Corp | $124.37 | 2019-2022 | |
| Astellas Pharma US INC | $119.18 | 2019-2025 | Xtandi, Myrbetriq |
| 180 Medical, INC. | $113.69 | 2021-2025 | |
| Myovant Sciences INC. | $112.05 | 2021-2022 | |
| Medtronic USA, INC. | $106.35 | 2019 | |
| Allergan, INC. | $97.64 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $88.35 | 2019-2025 | Adstiladrin |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $86.01 | 2023-2025 | Gemtesa, Orgovyx |
| Immunitybio, INC. | $71.96 | 2025 | |
| Dentsply Ih Ab | $66.30 | 2024 | Lofric |
| Urogen Pharma, INC. | $65.67 | 2021-2025 | Jelmyto |
| Myriad Genetic Laboratories, INC. | $62.88 | 2024 | Prolaris |
| Abc Home Medical Supply, INC. | $59.58 | 2025 | |
| Dendreon Pharmaceuticals LLC | $57.91 | 2024-2025 | Provenge |
| Teleflex LLC | $56.80 | 2021-2024 | Solesta |
| Pfizer INC. | $54.17 | 2019-2020 | |
| Neotract INC. | $49.79 | 2019-2020 | |
| Hollister Incorporated | $48.82 | 2021-2023 | Infyna Chic |
| Bioprotect Medical, INC. | $48.43 | 2025 | Bioprotect Balloon Implant System |
| Tolmar Pharmaceuticals, INC. | $38.22 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $33.85 | 2023-2024 | Keytruda, Lynparza |
| Bayer Healthcare Pharmaceuticals INC. | $29.40 | 2021-2023 | |
| Progenics Pharmaceuticals, INC. | $28.87 | 2025 | |
| Acerus Pharmaceuticals Corporation | $27.82 | 2020-2021 | |
| Urovant Sciences INC | $26.67 | 2021-2022 | |
| Agiliti Surgical, INC. | $26.15 | 2024 | Dornier Thulio, Sonablate Hifu |
| C. R. Bard, INC. & Subsidiaries | $20.55 | 2023 | Bard Urinary Drainage Bag |
| Dentsply Ih INC. | $18.75 | 2020 | |
| Mission Pharmacal Company | $16.19 | 2022 | |
| Antares Pharma, INC. | $14.78 | 2019 | |
| Verity Pharmaceuticals INC. | $14.39 | 2022 | |
| Alnylam Pharmaceuticals INC. | $13.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robyn Leitner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.